Clinical characteristics of patients with maintenance hemodialysis affected by COVID‑19: A single‑center retrospective study

Zhang,Guoqing; Ma,Danna; Li,Bo; Bao,Li; Luo,Hongyan; Cao,Shilu; Zheng,Yali

doi:10.3892/etm.2024.12757

Clinical characteristics of patients with maintenance hemodialysis affected by COVID‑19: A single‑center retrospective study

Authors:
- Guoqing Zhang
- Danna Ma
- Bo Li
- Li Bao
- Hongyan Luo
- Shilu Cao
- Yali Zheng
View Affiliations

Affiliations: The Third Clinical Medical College, Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region 750000, P.R. China, Department of Nephrology, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, Ningxia Hui Autonomous Region 750000, P.R. China
Published online on: October 29, 2024 https://doi.org/10.3892/etm.2024.12757
Article Number: 7
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The coronavirus disease 2019 (COVID‑19) is spreading continuously worldwide. Maintenance hemodialysis (MHD) patients are a particular group at higher risk of contracting COVID‑19. The aim of the present study was to investigate the various risk factors that contribute to the occurrence of co‑infection with COVID‑19 among patients with MHD. A retrospective analysis was conducted on 171 patients with MHD. The characteristics and outcomes were examined among patients with MHD who were infected with COVID‑19 and those who were not. Moreover, risk factors associated with survival or mortality among the COVID‑19‑infected patients with MHD were analyzed. The results of the present study revealed that the mean level of 25‑hydroxyvitamin D [25(OH)D] in patients with MHD was 22.3±11.28 ng/ml. However, there was no significant difference in the levels of 25(OH)D between patients with MHD with and without COVID‑19. Logistic regression analysis revealed that decreased levels of intact parathyroid hormone (iPTH) and increased levels of serum ferritin were associated with an increased risk of COVID‑19 in these patients. Additionally, the levels of 25(OH)D and albumin were decreased in the deceased patients. Similarly, logistic regression analysis was performed to identify risk factors for mortality in patients with MHD with COVID‑19, which revealed that decreased levels of 25(OH)D were associated with an increased risk of mortality in these patients. The results of the present study indicated that iPTH and serum ferritin levels could potentially increase the risk of COVID‑19 among patients with MHD. Additionally, 25(OH)D levels may influence the mortality rate among patients with MHD who have been infected with COVID‑19.

View Figures

View References

1	Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, et al: Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 382:1708–1720. 2020.PubMed/NCBI View Article : Google Scholar
2	Gudbjartsson DF, Helgason A, Jonsson H, Magnusson OT, Melsted P, Norddahl GL, Saemundsdottir J, Sigurdsson A, Sulem P, Agustsdottir AB, et al: Spread of SARS-CoV-2 in the Icelandic population. N Engl J Med. 382:2302–2315. 2020.PubMed/NCBI View Article : Google Scholar
3	Allan M, Lièvre M, Laurenson-Schafer H, de Barros S, Jinnai Y, Andrews S, Stricker T, Formigo JP, Schultz C, Perrocheau A and Fitzner J: The World Health Organization COVID-19 surceillance database. Int J Equity Health. 21 (Suppl 3)(S167)2022.PubMed/NCBI View Article : Google Scholar
4	Ng JH, Hirsch JS, Wanchoo R, Sachdeva M, Sakhiya V, Hong S, Jhaveri KD and Fishbane S: Northwell COVID-19 Research Consortium and the Northwell Nephrology COVID-19 Research Consortium. Outcomes of patients with end-stage kidney disease hospitalized with COVID-19. Kidney Int. 98:1530–1539. 2020.PubMed/NCBI View Article : Google Scholar
5	Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, et al: Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 323:1574–1581. 2020.PubMed/NCBI View Article : Google Scholar
6	Lechien JR, Chiesa-Estomba CM, Place S, Van Laethem Y, Cabaraux P, Mat Q, Huet K, Plzak J, Horoi M, Hans S, et al: Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. J Intern Med. 288:335–344. 2020.PubMed/NCBI View Article : Google Scholar
7	Hilbrands LB, Duivenvoorden R, Vart P, Franssen CFM, Hemmelder MH, Jager KJ, Kieneker LM, Noordzij M, Pena MJ, de Vries H, et al: COVID-19-related mortality in kidney transplant and dialysis patients: Results of the ERACODA collaboration. Nephrol Dial Transplant. 35:1973–1983. 2020.PubMed/NCBI View Article : Google Scholar
8	Popov GT, Baymakova M, Vaseva V, Kundurzhiev T and Mutafchiyski V: Clinical characteristics of hospitalized patients with COVID-19 in Sofia, Bulgaria. Vector Borne Zoonotic Dis. 20:910–915. 2020.PubMed/NCBI View Article : Google Scholar
9	Vaziri ND, Pahl MV, Crum A and Norris K: Effect of uremia on structure and function of immune system. J Ren Nutr. 22:149–156. 2012.PubMed/NCBI View Article : Google Scholar
10	Khatri M, Islam S, Dutka P, Carson J, Drakakis J, Imbriano L, Jawaid I, Mehta T, Miyawaki N, Wu E, et al: COVID-19 antibodies and outcomes among outpatient maintenance hemodialysis patients. Kidney360. 2:263–269. 2021.PubMed/NCBI View Article : Google Scholar
11	Peelen E, Knippenberg S, Muris AH, Thewissen M, Smolders J, Tervaert JW, Hupperts R and Damoiseaux J: Effects of vitamin D on the peripheral adaptive immune system: A review. Autoimmun Rev. 10:733–743. 2011.PubMed/NCBI View Article : Google Scholar
12	Drechsler C, Pilz S, Obermayer-Pietsch B, Verduijn M, Tomaschitz A, Krane V, Espe K, Dekker F, Brandenburg V, März W, et al: Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients. Eur Heart J. 31:2253–2261. 2010.PubMed/NCBI View Article : Google Scholar
13	Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, Dubnov-Raz G, Esposito S, Ganmaa D, Ginde AA, et al: Vitamin D supplementation to prevent acute respiratory tract infections: Systematic review and meta-analysis of individual participant data. BMJ. 356(i6583)2017.PubMed/NCBI View Article : Google Scholar
14	Kaufman HW, Niles JK, Kroll MH, Bi C and Holick MF: SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels. PLoS One. 15(e239252)2020.PubMed/NCBI View Article : Google Scholar
15	Meltzer DO, Best TJ, Zhang H, Vokes T, Arora V and Solway J: Association of vitamin D status and other clinical characteristics with COVID-19 test results. JAMA Netw Open. 3(e2019722)2020.PubMed/NCBI View Article : Google Scholar
16	Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29(e45)2001.PubMed/NCBI View Article : Google Scholar
17	Pan F, Ye T, Sun P, Gui S, Liang B, Li L, Zheng D, Wang J, Hesketh RL, Yang L and Zheng C: Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19). Radiology. 295:715–721. 2020.PubMed/NCBI View Article : Google Scholar
18	Chiang WF, Hsiao PJ and Chan JS: Vitamin D for recovery of COVID-19 in patients with chronic kidney disease. Front Nutr. 9(930176)2022.PubMed/NCBI View Article : Google Scholar
19	Meier P, Dayer E, Blanc E and Wauters JP: Early T cell activation correlates with expression of apoptosis markers in patients with end-stage renal disease. J Am Soc Nephrol. 13:204–212. 2002.PubMed/NCBI View Article : Google Scholar
20	Barek MA, Aziz MA and Islam MS: Impact of age, sex, comorbidities and clinical symptoms on the severity of COVID-19 cases: A meta-analysis with 55 studies and 10014 cases. Heliyon. 6(e5684)2020.PubMed/NCBI View Article : Google Scholar
21	Tentori F, Wang M, Bieber BA, Karaboyas A, Li Y, Jacobson SH, Andreucci VE, Fukagawa M, Frimat L, Mendelssohn DC, et al: Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: The DOPPS study. Clin J Am Soc Nephrol. 10:98–109. 2015.PubMed/NCBI View Article : Google Scholar
22	Hong YA, Kim JH, Kim YK, Chang YK, Park CW, Kim SY, Kim YS, Kang SW, Kim NH, Kim YL and Yang CW: Low parathyroid hormone level predicts infection-related mortality in incident dialysis patients: A prospective cohort study. Korean J Intern Med. 35:160–170. 2020.PubMed/NCBI View Article : Google Scholar
23	Dukkipati R, Kovesdy CP, Colman S, Budoff MJ, Nissenson AR, Sprague SM, Kopple JD and Kalantar-Zadeh K: Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients. J Ren Nutr. 20:243–254. 2010.PubMed/NCBI View Article : Google Scholar
24	Fukagawa M, Akizawa T and Kurokawa K: Is aplastic osteodystrophy a disease of malnutrition? Curr Opin Nephrol Hypertens. 9:363–367. 2000.PubMed/NCBI View Article : Google Scholar
25	Topless R, Green R, Morgan SL, Robinson P, Merriman T and Gaffo AL: Folic acid and methotrexate use and their association with COVID-19 diagnosis and mortality: A case-control analysis from the UK Biobank. BMJ Open. 12(e62945)2022.PubMed/NCBI View Article : Google Scholar
26	Itelman E, Wasserstrum Y, Segev A, Avaky C, Negru L, Cohen D, Turpashvili N, Anani S, Zilber E, Lasman N, et al: Clinical characterization of 162 COVID-19 patients in Israel: Preliminary report from a large tertiary center. Isr Med Assoc J. 22:271–274. 2020.PubMed/NCBI
27	Aranow C: Vitamin D and the immune system. J Investig Med. 59:881–886. 2011.PubMed/NCBI View Article : Google Scholar
28	Glinsky GV: Tripartite combination of candidate pandemic mitigation agents: Vitamin D, quercetin, and estradiol manifest properties of medicinal agents for targeted mitigation of the COVID-19 pandemic defined by genomics-guided tracing of SARS-CoV-2 targets in human cells. Biomedicines. 8(129)2020.PubMed/NCBI View Article : Google Scholar
29	Bhan I, Burnett-Bowie SAM, Ye J, Tonelli M and Thadhani R: Clinical measures identify vitamin D deficiency in dialysis. Clin J Am Soc Nephrol. 5:460–467. 2010.PubMed/NCBI View Article : Google Scholar
30	Nigwekar SU, Bhan I and Thadhani R: Nutritional vitamin D in dialysis patients: What to D-iscern? Nephrol Dial Transplant. 26:764–766. 2011.PubMed/NCBI View Article : Google Scholar
31	Qin S, Li W, Shi X, Wu Y, Wang C, Shen J, Pang R, He B, Zhao J, Qiao Q, et al: 3044 cases reveal important prognosis signatures of COVID-19 patients. Comput Struct Biotechnol J. 19:1163–1175. 2021.PubMed/NCBI View Article : Google Scholar
32	Huang J, Cheng A, Kumar R, Fang Y, Chen G, Zhu Y and Lin S: Hypoalbuminemia predicts the outcome of COVID-19 independent of age and co-morbidity. J Med Virol. 92:2152–2158. 2020.PubMed/NCBI View Article : Google Scholar